Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies
Keywords: Triazoles; Triazolothiadiazoles; Anticancer; Cdc25 phosphatase; Docking; ADME-T;